Amid regulatory troubles related to his huge stake in his eponymous firm, Icahn made some interesting stock moves.

Activist investor Carl Icahn has tightened his hold on pharmaceutical company Bausch Health. Dana has entered an agreement to add two new board members picked by Carl Icahn’s company, one of whom is ...

Icahn Enterprises (NasdaqGS:IEP) reported Q1 results that fell short of expectations, driven by losses on refining hedges and unrealized derivative losses. Outgoing CEO Andrew Teno highlighted ...

Billionaire investor Carl Icahn quietly outperformed Berkshire Hathaway Inc. during the first quarter. Icahn Outpaces Buffett ...

Fertitta Entertainment will acquire Caesars Entertainment for roughly $18 billion in an all-cash deal, including $11.9B in ...

Carl Icahn-owned investment firm Icahn Enterprises on Friday halved its quarterly payout, months after short-seller Hindenburg Research accused it of operating a “Ponzi-like” structure to pay ...

Shares of billionaire investor Carl Icahn’s holding company rallied Monday to their highest price since mid-May after the 87-year-old decoupled collateral for personal loans with his position in Icahn ...

NEW YORK (Reuters) -Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker's board, two ...

Carl Icahn said in a recent interview that he's bracing for a fight against Hindenburg Research after its report last month cratered his personal fortune. The 87-year-old activist investor told ...